With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
BD and Waters set completion date for $17.5B biosciences and diagnostics merger
BD (Becton, Dickinson and Company) and Waters Corporation have set Feb. 9 as the completion date for their $17.5 billion biosciences and diagnostics merger, following Waters shareholders’ approval to issue stock. BD will spin off its biosciences and diagnostics business and merge it with a Waters subsidiary, giving BD shareholders about 39.2% of the combined…